Gradient Investments LLC raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 260.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,844 shares of the healthcare conglomerate’s stock after buying an additional 1,333 shares during the period. Gradient Investments LLC’s holdings in UnitedHealth Group were worth $342,000 at the end of the most recent reporting period.
A number of other institutional investors have also bought and sold shares of UNH. SNS Financial Group LLC raised its position in UnitedHealth Group by 4.0% in the fourth quarter. SNS Financial Group LLC now owns 5,856 shares of the healthcare conglomerate’s stock worth $937,000 after buying an additional 227 shares in the last quarter. Sowell Financial Services LLC acquired a new position in UnitedHealth Group during the fourth quarter worth approximately $236,000. WFG Advisors LP raised its position in UnitedHealth Group by 214.8% in the fourth quarter. WFG Advisors LP now owns 15,735 shares of the healthcare conglomerate’s stock worth $251,000 after buying an additional 10,736 shares in the last quarter. Norges Bank acquired a new position in UnitedHealth Group during the fourth quarter worth approximately $1,530,177,000. Finally, Vident Investment Advisory LLC raised its position in UnitedHealth Group by 8.5% in the fourth quarter. Vident Investment Advisory LLC now owns 17,500 shares of the healthcare conglomerate’s stock worth $2,801,000 after buying an additional 1,372 shares in the last quarter. 86.26% of the stock is currently owned by institutional investors.
UnitedHealth Group Incorporated (NYSE:UNH) traded up 0.06% during trading on Friday, reaching $194.88. The company’s stock had a trading volume of 2,892,259 shares. The firm has a 50 day moving average price of $186.80 and a 200-day moving average price of $173.05. UnitedHealth Group Incorporated has a 52-week low of $132.39 and a 52-week high of $196.04. The stock has a market cap of $191.96 billion, a price-to-earnings ratio of 23.41 and a beta of 0.64.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.38 by $0.08. The firm had revenue of $50.05 billion for the quarter, compared to the consensus estimate of $49.97 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The business’s quarterly revenue was up 7.7% compared to the same quarter last year. During the same period in the previous year, the business earned $1.96 EPS. On average, analysts expect that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current year.
COPYRIGHT VIOLATION WARNING: This news story was originally reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of US and international trademark and copyright law. The legal version of this news story can be accessed at https://stocknewstimes.com/2017/08/06/unitedhealth-group-incorporated-nyseunh-stake-raised-by-gradient-investments-llc.html.
A number of equities analysts have commented on UNH shares. Mizuho boosted their price objective on UnitedHealth Group from $178.00 to $200.00 and gave the stock a “buy” rating in a research note on Tuesday, April 18th. Stifel Nicolaus reissued a “buy” rating and issued a $185.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, April 19th. Evercore ISI reissued an “outperform” rating and issued a $185.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, April 19th. Credit Suisse Group boosted their price objective on UnitedHealth Group from $185.00 to $188.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 19th. Finally, Deutsche Bank AG reissued a “buy” rating and issued a $187.00 price objective (up previously from $183.00) on shares of UnitedHealth Group in a research note on Saturday, April 22nd. One equities research analyst has rated the stock with a hold rating and twenty-four have assigned a buy rating to the company. UnitedHealth Group has an average rating of “Buy” and an average target price of $200.24.
In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,540 shares of UnitedHealth Group stock in a transaction dated Friday, June 2nd. The stock was sold at an average price of $178.74, for a total transaction of $990,219.60. Following the transaction, the director now directly owns 60,516 shares of the company’s stock, valued at approximately $10,816,629.84. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction dated Wednesday, June 7th. The stock was sold at an average price of $182.64, for a total value of $913,200.00. Following the transaction, the director now directly owns 75,735 shares in the company, valued at $13,832,240.40. The disclosure for this sale can be found here. Insiders have sold a total of 15,540 shares of company stock worth $2,873,320 over the last ninety days. Company insiders own 0.89% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.
